Actively Recruiting

Age: 65Years +
All Genders
ID02434393

Characterizing Cognitive Decline in Late Life Depression: The Alzheimer's Disease Neuroimaging Initiative - Depression Project

Led by University of Southern California · Updated on 2025-11-25

120

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of Southern California

Lead Sponsor

N

National Institute of Mental Health (NIMH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying the factors that contribute to cognitive impairment and faster cognitive decline in people with Late Life Depression (LLD). This observational research aims to understand these changes without providing treatment. The study began in 2015, initially enrolling 133 participants, and will continue by enrolling 120 participants over 30 months, including both continuing participants and new enrollees. Data from 300 non-depressed individuals will be used for comparison. Participants with Major Depression or Late Life Depression will be followed without treatment. Assessments will include magnetic resonance imaging (MRI) scans and positron emission tomography (PET) scans for amyloid and tau proteins. Blood samples will be collected for genetic and biomarker analysis. Clinical and cognitive tests will be done at two time points during the study. Participants will undergo evaluations including depression history, symptom severity, and health information at the start. They will have brain scans and blood drawn at specified visits. Researchers will measure changes in memory, executive function, language skills, brain structure, and protein deposits over five years. Genetic studies using collected data will also be conducted. The study is planned to continue through May 2027.

CONDITIONS

Brief Title

Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project

Who Can Participate

Age: 65Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Individual participated in original Characterizing Cognitive Decline in Late Life Depression study or Multimodal MRI Characteristics of Psychotherapy Response in Late Life Depression Study.
  • Antidepressant medication treatment is allowed only if the medication dose is stable for 4 weeks prior to the MRI scan.
  • Psychotherapy interventions are allowed only if participants have completed at least 4 weeks of individual or group psychotherapy prior to the MRI scan.
  • Participants taking cognitive enhancing medications may enter the study.
Not Eligible

You will not qualify if you...

  • None specified beyond inclusion exceptions; stable medication and psychotherapy requirements must be met.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Diagnostic Evaluation

Duration - 5 years

Participants undergo assessments including neuropsychological tests, MRI scans, and biomarker measurements to characterize cognitive decline.

Regular assessments during the 5-year period

Long-term Monitoring

Duration - 5 years

Participants are monitored over time to track changes in cognitive function and brain structure.

Periodic visits for follow-up assessments during the 5-year period

Trial Site Locations

Total: 2 locations

1

University of California, San Francisco

San Francisco, California, United States, 94143

Actively Recruiting

2

University of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15213

Completed

Loading map...

Research Team

N

Nithya Ganesh

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Accelerated High-Dose tDCS for Depression: An Open-Label Out...

Major Depression

Actively Recruiting

1 location

Accelerated versus Conventional Theta Burst Stimulation for ...

Late Life Depression (LLD)

Actively Recruiting

2 locations

Added Value of a Neuroendocrine Test Battery in the Response...

Major Depression

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Depression predicts mortality in the young old, but not in the oldest old: results from the Berlin Aging Study.

Michael A Rapp, Denis Gerstorf, Hanfried Helmchen...

https://pubmed.ncbi.nlm.nih.gov/18827231